Topic

Novo Nordisk

Latest Daily Tribune news and analysis on Novo Nordisk.

Novo pushes new obesity care approach
Novo Nordisk launches its ‘Live Lighter’ movement in the Philippines, introducing a semaglutide-based obesity treatment and a nationwide push to treat obesity…
24 April 20261 MIN READ
Up to 1.5 million Americans using compounded weight-loss drugs
Up to 1.5 million Americans may be using compounded versions of GLP-1 weight-loss drugs, Novo Nordisk CEO Mike Doustdar said, highlighting how cheaper…
13 January 20261 MIN READ
EMA flags rare vision risk in users of weight-loss drugs
7 June 20253 MIN READ
Novo Nordisk reports 21% profit jump in 2024
Novo Nordisk sees a 21% profit surge in 2024, driven by strong sales of diabetes and weight-loss drugs Ozempic and Wegovy, totaling 100 billion Danish kroner.
5 February 20251 MIN READ